1,3,3,3′,3′-Pentaisopropyl-1,3,3′,6,6′,7,7′-heptahydro-1λ5-1,1′-spirobi[acenaphtho 5,6-cd][1,2,6]oxadiphosphinine]-3,3′-diium Triiodide
Round 1
Reviewer 1 Report
The article „ 1,3,3,3',3'-Pentaisopropyl-1,3,3',6,6',7,7'-heptahydro-1λ5-1,1'-spirobi[acenaphtho[5,6-cd][1,2,6]oxadiphosphinine]-3,3'-diium triiodide” is interesting and fits within the Molebank scope. There are a few errors or inaccuracies in the article that need to be corrected, below is a list of points with elements to be corrected:
- the abstract definitely needs to be completed, according to the instructions for authors Molbank should contain information on the methods, result and conclusions
- the diagram on page 2, which is referenced numerous times in the introduction, should have the caption "Scheme 1"
- “thf” should be replaced with “THF” and the abbreviation should be explained (line 46)
- there are no IUPAC names for the final product
- Ref 15 should be removed and added directly in the text
- the supplement on page 3 contains redundant information
- The supplement should necessarily include NMR spectras (as well as other data, e.g. Raman, IR or MS), which are described in the article
Author Response
Please find our response in the attached file.
Author Response File: 
Author Response.pdf
